Flotek Industries, Inc. (FTK) Earnings Call Transcript & Summary

August 6, 2020

New York Stock Exchange US Materials Chemicals earnings 42 min

Earnings Call Speaker Segments

Danielle Allen

executive
#1

Thanks, and good morning to all of you. We're glad you could join us. On the line with me today are John Gibson, our Chairman, Chief Executive Officer and President; Michael Borton, our Chief Financial Officer; TengBeng Koid, President of Global Business; and Ryan Ezell, President of Chemistry Technologies. During this call, we'll begin with prepared comments about our business and the quarter's results. After that, we'll take whatever questions you have. Our earnings announcement for the second quarter came out yesterday and can be found on our website. Also note that a supplemental presentation has been posted there as well. A webcast of today's call is underway, and a replay will be accessible on our website too. Keep in mind that anything we say today about projections or what we expect in future events counts as forward-looking statements. Such statements carry a number of risks and uncertainties, and many of those lie outside our control. Actual results could differ materially from what we currently expect because of these risks and uncertainties. Listeners should review our earnings release and the risk factors covered in our SEC filings; in addition, please see the reconciliations in our earnings press release, since management might discuss non-GAAP metrics today. I'll hand things over to John now.

John Gibson

executive
#2

Thank you so much, Danielle. As we confront these remarkable circumstances side by side, both as an organization and as a nation, I feel tremendous appreciation toward our team members for their dedication, hard work, and inventive spirit. Making sure our staff, clients, and the areas in which we operate stay safe comes first, and we keep working to deliver a secure workplace for everyone despite extremely difficult conditions. Given our solid financial standing, with minimal borrowing and a robust cash balance, we are lucky to be ideally situated for this market. Flotek places great emphasis on nurturing a startup-minded culture made up of gifted, driven individuals who possess unwavering integrity. That will enable us to advance quickly and with clear purpose. These traits of Flotek matter enormously for preparing our business for what lies ahead. With that in mind, I want to share some news about our leadership group and afterward dig deeper into the broader landscape and what Flotek is doing, especially regarding fresh avenues for expansion. Now, the management transitions. One of the greatest joys of my role is spotting and cultivating leaders capable of creating a distinctive, top-tier operation that capitalizes on the remarkable possibilities in front of us; and we have such a team. This group is enterprising, able to collaborate in order to deliver value for every one of our stakeholders through one of the hardest periods ever seen. So I am delighted to present the newest members of our leadership group, who are assisting in getting Flotek ready for upcoming growth. To start, I am truly thrilled that Mike Borton has come aboard as Chief Financial Officer. Mike is a formidable finance and operations executive with deep expertise in establishing and speeding up expansion for digital and Software as a Service businesses. Another major asset Mike brings is managing costs. And I believe you will notice that he aligns closely with the way this organization handles the things within its control. After that, we are happy to welcome TengBeng Koid into the brand-new position of President of the global business, where he supervises our strategy for domestic and overseas business development across both Flotek divisions. Among Koid's main duties is speeding up the shift of JP3's data as a service and unlocking entry to additional markets. I sincerely hope you will spend some time looking over his background, since it speaks for itself. Working alongside TengBeng Koid previously around the globe has been a delight. It is likewise a real pleasure to collaborate with Mike and Koid once more, given that we all served together at The Landmark and afterward Halliburton, and from my own experience, the two of them have proven themselves under fire and their records are flawless. After that, I am delighted to share that Ryan Ezell has been promoted into the brand-new position of President of the Chemistry Technology. Ryan’s most recent role was Senior Vice President of Operations at the company, and over the period I’ve gotten to know him, I’ve seen firsthand his resolute leadership, his unyielding emphasis on running operations well and generating profit, plus his extensive expertise in Flotek’s specialty chemistry — he also holds a PhD in Chemistry. Another thing I should mention about him is the enormous passion he has for his people, and he has kept going out to the sites, engaging with employees through this difficult stretch and showing leadership right there on the ground. I genuinely, genuinely value Ryan. He is absolutely an asset. And I have complete trust in his capacity to head our chemistry technology segment. I’m glad to present each of them to you in their new positions, and you’ll hear straight from them during the call. They complete a very robust management team. Finally, a significant Board update; this morning we shared that Harsha Agadi has come aboard Flotek as Director and Chair of our Compensation Committee. He carries remarkable experience earned from roles as a Senior Executive at Fortune 50 companies and leading global brands including Crawford & Company, Friendly’s Ice Cream Corporation, Church’s Chicken and Little Ceasar’s Enterprises. My personal favorite, naturally, was Krystal, having grown up in the South. Several of us here hope he’ll introduce us there, something every good Southern Board understands very well, though perhaps not familiar to some of you out West. But he’s a dynamic and deeply committed leader who genuinely cares about the companies and organizations he’s connected to. When we started our sanitizer business, we felt truly thankful for his deep understanding of that market, along with the insights and connections across key market segments that require these premium products, and we’re eager to put that network from Harsha to use. Now let’s turn to what’s likely the least enjoyable aspect of anyone’s stock this quarter, and that’s the macro environment. During this earnings call, you’ve surely heard about the tremendous difficulties the oil and gas market has faced, stemming from demand destruction caused by government responses to COVID-19 and excess supply in the market, which was worsened by the Saudi-Russia Price Board. We’ve watched prices plummet. Levels never anticipated, with gasoline demand dropping roughly 45% in April by itself. US refinery utilization fell under 70% driven by steep cuts in travel, and by early May, operators were announcing budgets with us down over 40%, with some going even more drastically. I won’t take too long repeating what you already know, but it was an unbelievably hard quarter, among the toughest I’ve seen in my career; even so, in this climate, you have to hunt for chances to improve and manage what’s within your control, and that’s where our team has concentrated; we are definitely not pleased about the macroenvironment conditions or the difficulties COVID has brought. But even so, we're responding to what our customers require by concentrating on ways to broaden our business beyond rig count and drill bit, while also seizing unique chances tied to the digital transformation of the energy industry and using our robust specialty chemical strengths to make FDA registered, high-quality sanitizers and surface cleaners — each of these fits alongside Flotek's Industries top chemistry applications and provides a permanently domestically sourced supply for these leaded products. On the subject of liquidity in the cost measures, I want to speak to that too, since we're setting ourselves up for what's ahead, and we've moved swiftly and firmly, using our strategic pillars as a guide, to safeguard our liquidity and financial flexibility; our balance sheet is healthy, with very little debt remaining. Our method for capital allocation has been disciplined. Earlier, across the past several months, we looked at a number of inorganic possibilities. And we turned down multiple acquisition opportunities that appeared attractive and that would have fit well with our business; yet doing so would have meant taking on extra debt — in certain cases, a substantial amount — so we declined every one of them, and on the enhanced side, that looks like the correct call; we keep taking additional steps to shore up our balance sheet position, and it's called out many initiatives, from a reduction in workforce to lowering compensation to cutting back discretionary spending; on top of that, we're zeroed in on inventory rationalization and think we'll find ways to boost our liquidity moving forward.

John Gibson

executive
#3

Shortly, Mike will take a closer look at liquidity. Something that appears in nearly every research report you pick up is digital transformation—energy customers continue to seek actionable, real-time data and insights they can put to use, since that produces a meaningful business result, or put more simply, stronger profitability. A detailed Evercore study published in June 2020 that examined our digital transformation found that more than 90% of the energy executives who responded believe technology and digital transformation will be critical for increasing their profitability and achieving cost savings, and those factors were identified as leading reasons for adoption to improve their business. Our acquisition of JP3 — a data tech firm that brings innovation — is now letting us assist clients in accelerating their shift to digital operations. We do this by assembling valuation information in real time, which is required for overseeing crude oil and natural gas processing in today's digital era. There are strong strategic and financial advantages tied to buying JP3, because it spreads Flotek's activities across all parts of the hydrocarbon value chain, starting at the wellhead and going through to terminals for refined products. When the purchase was announced, we noted that JP3 achieved a 58% CAGR across the prior 4 years, and it also provides some protection against swings in rig count. Even so, it has felt the impact of difficult market circumstances, particularly the steep decline in demand for refined fuel products. As a result, second-quarter revenue was hit hard because customers nearly stopped their capital expenditures. Despite those tough market circumstances, JP3 is keeping its customers, securing repeat orders from those it already serves and bringing in multiple deals with new buyers. Given the substantial customer wealth we possess, we have confidence that a robust market need exists for JP3's distinctive data offerings, and we believe that once demand for oil and gas climbs, our sales should recover in step — that's the main reason we brought Koid on board. I'll now hand things over to him so he can discuss the growth opportunities at Flotek in greater detail. It's a real pleasure to have TengBeng Koid with us — he serves as President of Global Business — and I'm happy to hand things over to him.

Teng Beng Koid

executive
#4

Thanks, John. It's truly wonderful to be here and to collaborate with John once more. My work in digital solutions for oil and gas spans more than 30 years, and during the last 10 years, I headed a firm that assisted midstream oil and gas businesses in improving their operations via digital transformation. At JP3, we possess a distinctive and differentiated revolutionary technology that I am confident will reshape oil and gas firms by constantly gathering and examining real-time data. JP3 holds 22 patents, with an additional 16 patents in process. Since I came aboard roughly a month back, I've had the chance to talk with numerous current clients as well as quite a few prospective ones. Their feedback has been extremely favorable. The different applications where JP3 technology has been deployed generated considerable worth for our clients. A single illustration of this kind of worth generation is the decrease of refined products transmits for pipelines and terminal operators, and following that we signed a data as a service cooperation agreement with Phillips 66. Under this agreement, we will together promote these services to every refined fuel transportation operator. Phillips 66 has already gotten things moving on this cooperation, and as they set up meetings at multiple refined fuel pipeline operators, it's fantastic to have our clients advocating for us, and that demonstrates the worth our technology provides. Additional instances of applications encompass crude blending and competition tracking; when it comes to competition tracking, we are upgrading what we offer, the abilities to gauge CO2, to fulfill the necessity for natural gas custody transfer requirements, and to aid our clients' ESG endeavors. As we've talked about before, JP3's emphasis historically has been on the North American market. Since arriving roughly 5 weeks back, we've begun investigating expansion into the international market; we encountered considerable interest in JP3's extremely differentiated technology from a number of nations across the Middle East, Africa, and Asia. We delivered presentations to these firms, among them the biggest oil and gas company in the Middle East and one of the biggest gas pipeline operators in India. We are implementing measures to tackle exports and other regulatory compliance, such as international standards certification, to guarantee that JP3 technology will be prepared for an international launch in 2021. I'm thrilled about the many possibilities to elevate this business to another level, and the total addressable market is enormous. With that, I'll hand the call over to Ryan, who will talk about our other growth engines.

Ryan Ezell

executive
#5

Appreciate that, Koid. I've got some good news — Flotek has rolled out a sanitizer and disinfectant product line that satisfies FDA quality requirements, designed for industrial settings along with everyday consumer uses. Our initial step came from community engagement efforts that kicked off in Q1, when we started producing hand sanitizer and distributing it at no cost to surrounding neighborhoods, first responders, hospitals, schools, homeless shelters, and senior living communities. From there, we identified an opportunity to expand our revenue sources by moving into a market showing renewed potential for strong growth — a logical extension of our Specialty Chemistry expertise. This allowed us to leverage our manufacturing capabilities and maximize utilization of our existing facilities. During the second quarter, we introduced sanitizer items that are registered with the FDA, and we're actively marketing them in a range of sectors—hospitals and medical facilities, travel and hospitality, food services, e-commerce and retail, sports entertainment, plus various industrial and consumer markets. To establish this line of business, we leveraged strengths we already possessed: developing and delivering specialty chemistries, manufacturing operations certified to ISO standards, dependable supply chain oversight, productive manufacturing capability, and an R&D presence that is highly regarded within the energy and chemicals sector. By applying our technical expertise and research and development capabilities, we're able to provide superior products that carry FDA registration. As you know, over 100 hand sanitizers are getting pulled from shelves due to regulatory breaches tied to the FDA's Directive. For anyone hoping to stick around as a significant competitor in this space over the long haul, quality has become more important than it's ever been. Flotek delivers premium products manufactured in America that truly distinguish themselves in the market. The active ingredients used in our sanitizer meet pharmaceutical grade standards and come from suppliers within the United States. Both our liquid and gel offerings are developed in Houston, then blended at our Texas and Oklahoma locations. Thanks to the adaptable nature of how we operate, we could shift our production footprint fast, relying on the identical chemical processes and plants that our energy chemistry technology division already had in place. That keeps upfront spending low for what could be a very sizable revenue chance. With our sanitizer push, you can see us adjusting and moving resources toward areas offering better payback, since that line combines minimal expense with strong margins. As things stand, our existing sites can blend as much as 2.1 million gallons of specialty chemistries every month across both energy chemistry technologies and sanitizer product lines. Beyond that, during 2019 the market for hand sanitizer reached close to three billion dollars; meanwhile, every other market saw growth freeze at 1400% between December 2019 and February 2020 because of demand tied to the COVID pandemic, yet analysts continue to expect solid expansion rates above 7% even once COVID is behind us, and we're eager to share more news as we grow our sales within this promising new space. At this point I'll hand things back over to John.

John Gibson

executive
#6

Thanks, Ryan. Our business model centered on energy has taken a hit in the near term, because demand stalled out with COVID 19 and oil prices got restructured, yet we feel sure our strategy remains sound, along with the steps we've laid out to put this company in a stronger spot going forward. Our vision for the long haul is a platform that maximizes profitability across the entire chain, starting at the reservoir and running through to where refined products end up. The chemistry we've innovated boosts how much of the reserves can ultimately be recovered. Data from JP3 adds a fresh profitability dimension, since it gauges how effective the injected chemistries are, and with JP3 becoming part of us, they now have capital on hand to genuinely scale that operation and move into global markets, plus our new sanitizer line gives us a fast-growing chance that draws on the chemical manufacturing capacity we already have, along with a brand-new market. Now, we realize it's tough to pin down when things worldwide will get back to normal, and with the danger of a second COVID wave, possible lockdowns, and unemployment that stays elevated, there is plenty to weigh, but our team is getting ready as we adjust by making operations more diverse so we can reduce the exposure that comes with the oil and gas sector. And even as we talk about that, it's genuinely thrilling—we actually have cameras watching our Marlow, Oklahoma facility. Over these past few weeks, when you glance at the floor, Ryan and I were discussing how many forklifts there are, and the activity is ramping up, along with the count of pads for the energy chemistry we're making and shipping. So it's quite thrilling to witness that momentum is starting to come back even on the energy chemistry side. Our real aim, then, is to take every one of these strengths and create shareholder value, with the objective of getting back to profitability quickly by delivering premium, differentiated solutions into our market. Right now, I believe this is a great moment to inform our finance team that John Gibson is no longer our interim CFO. We've got the genuine article. And Mike, over to you.

Mike Borton

executive
#7

Hello, everybody, and thanks for joining. Today marks my fourth day here, and I'm energized by what Flotek can become and by the chance to contribute a new direction shaped by my background in SaaS and technology. Over the coming days, I'm eager to engage with our investors and hear what matters to you. Because we closed the JP3 purchase during the prior quarter, our reporting now features 2 segments: chemistry technologies and data analytics. What we used to call the energy chemistry technology segment is now chemistry technologies, and it also covers the sanitizer business Ryan mentioned that we recently started up. The data analytics arm came about through the JP3 deal. Keep in mind as well that Q2 figures reflect JP3 operations only from May 18, 2020 onward. I want to flag that adjustments may be required in our cash flow statements tied to the February 2019 sale of Florida Chemical Company to ADM, along with the associated escrow accounts. We are carefully examining our earlier filed financial statements to determine whether any new clarifications are warranted. That said, at present we don't expect any effect on earnings or our cash position. We're aiming to file our 10-K near August 17; with a solid finance team and a new direction, we're confident we can resolve this matter as efficiently as possible. As John mentioned earlier, the second quarter proved difficult, with major industry headwinds weighing on both segments. Turning first to the income statement: consolidated revenue for Q2 came in at $8.9 million, versus $34.7 million a year earlier, and short of the $19.4 million recorded in Q1. This steep revenue drop stems mostly from ongoing turbulence in the macro picture for US onshore drilling and completion work, which has been affected by political and economic developments abroad. On top of that, COVID19 hurt our productivity, which in turn weakened customer demand for our services and products, apart from the sanitizer business. Consolidated operating expenses reached $11.6 million in Q2 2020, a 69.5% decrease from the $38.1 million posted in last year's second quarter. That reduction largely reflects a lower cost of sales stemming from reduced revenues, plus cuts in freight, personnel, and travel and entertainment costs. We're continuing to pursue expense cuts to boost supply chain and operational efficiency, and we're negotiating the amendment to our terpene contract in February. These steps will let us manage inventories, even though they'll be considerably lower ahead, producing further operating efficiencies. Corporate G&A landed at $5.4 million, compared with $6.1 million a year ago, thanks to fewer employees, less discretionary spending, and lower stock-based compensation and professional fees. Depreciation and amortization fell $1.7 million, to $0.5 million in Q2, against $2.1 million the year before. In Q2, R&D expenses came to $1.6 million, which was $2.1 million lower than a year ago. We posted a net loss from continuing operations of $9.6 million, equal to $0.14 per share, for the second quarter of 2020, versus a loss of $0.8 million, or $0.22 per diluted share, in the prior year. That $9.6 million loss contains a $0.6 million gain on disposal of long-lived assets tied to buying out what remained of the corporate headquarters lease at a significant discount, since we relocated all employees to the existing Proto Global Research and Innovation Center at the close of June. Adjusted EBITDA for Q2 was negative $6.8 million, an improvement from the $9.4 million loss in Q2 of last year. This better adjusted EBITDA stems mainly from the reduced expenses we discussed earlier; we'd also like to highlight that our EBITDA was almost unchanged from the prior quarter, even with a more than 54% sequential drop in sales, which shows the operational efficiency gains we're making. Now let's turn to how our balance sheet performed. As John noted earlier, our cash position remains healthy. On June 30, 2020, cash equivalence stood at $59.9 million, compared with $80.3 million at the end of the first quarter. To connect those figures, 4 key factors drove our cash position: first, $25 million flowed out as a cash payment for the JP3 acquisition; second, $6.6 million came in, reflecting our claim to the remaining balance of the January escrow from selling the Florida chemical business to ADM; third, $4.8 million came in as cash from the paycheck protection program loan under the CARES act; and fourth, $1 million went out for the lease termination of our corporate headquarters. We also got a $6.3 million cash refund, including interest, in July tied to the net operating loss carryback provision of the recently active CARES Act. Now I'll hand the call back to John for some closing remarks.

John Gibson

executive
#8

Thanks for that, Mike. Being the fresh face with only 3 days in the role and suddenly finding yourself on a call is no easy thing, so I'm grateful you stepped in. Looking ahead, uncertainty continues to surround the market environment. Offering guidance isn't something we plan to do right now, and ideally we won't do it later either. That said, during the previous quarter we talked about our goal of reaching break-even for this fiscal year, and those figures came from the best projections we had at the time. With the pandemic's drawn-out effects and capital spending in energy essentially grinding to a halt, our current view is that hitting break-even within the fiscal year will be more and more improbable, even though it remains the objective we're pursuing. We stay extremely entrepreneurial and nimble, shifting our approach toward businesses focused on growth, all while drawing on the advantages of our distinctive business model and the financial room we have to maneuver. To wrap up, I want to express gratitude to all of you for being with us on today's earnings call. And I especially want to acknowledge our finance team — Elan, Kent and Misty, and, I mean, they have — Savi, they've truly been troopers, working alongside me and giving everything they've got; I just want to single them out and offer my thanks. This has been a tough stretch for us and for the industry, with market conditions more volatile than anything we've seen before. We've moved quickly to adjust to the situation, sharpen where our business is focused, and genuinely drive top-line growth while improving profitability. On top of that, we've been cutting costs aggressively to soften the margin decline and put ourselves in position to win going forward, and I hope Mike's remarks made clear to you just how much EBITDA we held onto despite the enormous revenue fall. We're still enthusiastic about our newly completed acquisition of JP3, which will assist in speeding up our digital transformation strategy and dovetail with our chemistry applications business. The announcement we made today about establishing a premium great sanitizer operation shows how we're organically expanding our core business into growth areas; these 2 growth initiatives, we believe, will set our company up for market share gains and give it a promising future. We're thankful for our shareholders' backing. Working for you is something we love. We're grateful to our employees and partners for their dedication as we steer through this crisis. We'll keep wanting to bring you updates as we progress, and we'll be regularly highlighting our growth initiatives on upcoming calls; with that, Danielle, I'd like to hand it back; and let's open things up for questions.

Daniel Burke

analyst
#9

Let's take a look. John, I realize that visibility isn't strong right now, and I know you've spoken openly about how difficult it is to provide guidance, but we're still seeing Q3 completion activities increasing, along with your new initiatives. My assumption is that we'll see some incremental contribution — is there any reason we shouldn't expect the top line to rise sequentially in Q3?

John Gibson

executive
#10

Well, every morning I wake up praying that the top line will be bigger each quarter from here on out. And I don't really plan to offer any guidance, but nothing would suggest that we won't be well positioned in the market as it recovers. So Koid is putting in hard work on the JP3 front. I believe some of the largest opportunities there for us are international, as you pointed out. A great deal of regulatory work has to be completed before we can sell those internationally, including registration and ECCM numbers, and other technical activities have to be done, but we're on that path at this moment, and make big here with us and handling the legal aspects, Ryan and the sanitizer business. Demand there is strong, and we keep seeing opportunity there. So that was a fairly weak quarter. So I'm glad to set the bar there, so we ought to be above that, but that's essentially the only guidance I can offer you on that, Daniel.

Daniel Burke

analyst
#11

Got it. That's useful, thanks. To sum up, we're looking at 2.1 million gallons per month of blending capacity spread across chemistry. Could you share where utilization stands at present, and perhaps what it looked like for that capacity over roughly the last 2 or 3 years? Just to take us back to a period when the energy market was somewhat healthier.

John Gibson

executive
#12

Sure — back when the market was considerably healthier, you'd likely see far more of that capacity being used than we see today. We're somewhat hesitant to provide the capacity figure, the utilization figure, Daniel, since we're moving into a new market, and we truly don't want competitors learning how much we're able to produce and at what margins, because we believe certain competitive strategies are emerging in the sanitizer business, and we're working to learn. Historically, though, it likely had capabilities around 30% greater, and the method by which we've boosted capacity at present is truly quite straightforward. The capacity figure we're citing assumes an 8-hour day. So if you look at our facilities and consider how soon they could operate 24 hours a day — probably accounting for maintenance and other factors — by the close of a 24-hour day, we could likely reach somewhere in the mid-70s for overall utilization of those facilities, and in an ideal market, and I'm hoping Koid and Ryan can push us toward full utilization across a 24-hour period; but at this moment, we're only quoting an 8-hour per day Marlow-Waller facility capacity number, and we hope to begin discussing how we extend past those 8 hours as markets get better.

Daniel Burke

analyst
#13

Understood, that helps. Then perhaps one final item, only regarding JP3 — it's encouraging to witness the headway on that program involving Phillips 66, which the press release this morning put a spotlight on. Could you discuss, since it received some mention in the remarks, what comes next at this stage? In other words, would Phillips 66 be the obvious initial buyer? If that's the case, at what point might we witness that switching, possibly an existing client of meaningful scale, yet I simply want some clarity regarding the schedule going forward from here.

John Gibson

executive
#14

I'll pass it along as Koid would and line things up here, though let me begin by noting we're quite thrilled. We intend to examine a fresh ASG's offering tied to JP3, through which we're aiming to gain the capability with sites owned by third parties, or to examine CO2 and have clients visiting this week to check that out. In our view, the ESG sector essentially attached to our existing position will prove enormous for us, plus adjusting the desktop so we can genuinely deliver the whole thing — I believe it's currently in fairly solid condition. But Koid, how do you view that unfolding?

Teng Beng Koid

executive
#15

Phillips 66 has rolled out this technology throughout every one of its refined fuel pipelines and terminals, and the value they're seeing is substantial — that's the reason they have confidence in the partnership we're starting. They've begun lining up customers so that we can make presentations together; in fact, Monday of next week is when the first one will present, that initial customer they've arranged, and a few more are also being lined up; these meetings are being scheduled with senior-level people at our customer sites, so we're genuinely thrilled about it, and then to have a customer offer testimony about the value we provide and be able to present jointly with us to other customers.

Eric Swergold

analyst
#16

Eric Swergold speaking. John, speaking for the shareholders, I appreciate you bringing the machete to Flotek's cost structure and carrying out precisely what you promised when you arrived and assumed the role. I'm also grateful today for the introduction to the team, new as they are. Hearing from some of the fresh faces is good. There are 2 questions from me. First, could you provide a sense of how large the NOLs on Flotek's balance sheet happen to be? Since it appears that once profitability comes back, it might be quite a while before any taxes get paid by us.

John Gibson

executive
#17

Mike, why don't you jump in.

Mike Borton

executive
#18

Like we mentioned before, at the close of last year we had approximately a bit more than 49. A portion of that went toward securing a favorable cash inflow back from the federal government, which came in during July. We also believe — so after that it sits at roughly 43 net, and then we figure we're producing about the same across the first 6 months of the year; so we're likely above 80; we haven't truly examined that level of fine detail yet, but we're likely sitting in the $80 million range right now.

Eric Swergold

analyst
#19

So NOLs give you more than $1 per share.

John Gibson

executive
#20

That's quite near, and by making use of the CARES Act we managed to lower it somewhat, going back and collecting that $6 million there. Excellent. Still, in my view that was the right move to make.

Eric Swergold

analyst
#21

Right. Then my follow-up concerns JP3 along with this fresh data-as-a-service operation. That's a business line unfamiliar to me, and likely unfamiliar to a lot of us holding shares; so I keep asking myself whether the plan is for JP3 to serve as a vehicle for picking up more companies in data-as-a-service, or whether this is simply a single deal?

John Gibson

executive
#22

Appreciate that question, and the reason we acquired it was our belief it could function as a platform — their analytics, plus the way they examine crude and analyze crude. What's happening is the energy sector shifting away from gravity as its measurement method toward composition as its measurement method, and there are so many paths stemming from that which lie open to us. Eric, take me as a refiner — among my most critical tasks is keeping the feedstock arriving consistent, which means deciding whose supply to purchase and how to blend it, so my feedstock stays continuous. So the entire upstream portion of the operation, and how they might work that purchasing out, is thrilling, along with how we might take part in it. The ESG piece genuinely excites us — examining minor components that prove expensive for them and for the refinery, plus pursuing automation and robotization built on that data — so a great many companies are on our radar. We simply have to — honestly, what I'd prefer to concentrate on right now is getting JP3 truly profitable and landing some of those accounts we believe are very nearly within reach between today and January 1, especially regarding internationalization and regarding the sanitizer business. In my view Ryan is performing exceptionally well there; so yes, I believe it's a chance to acquire something, and sanitizer is purely a growth engine for us, though it likewise carries new products…

Eric Swergold

analyst
#23

Great. Then, if I may squeeze in a third question, despite having mentioned only 2. Your own executive compensation, along with that of the rest of the team, looks like a substantial payout at $7, which comes to 4.5 times the present share prices — could you share a bit of your reasoning behind adopting such a shareholder friendly executive comp structure, one where you have to earn a ton of money for all of us before you folks truly earn good money for yourselves.

John Gibson

executive
#24

Well, let me flip that around a little and ask, how will you keep all of us together once we reach 7 there. So I think — let me offer some sense of the confidence I have in the people here in the room, we've started discussing what we do once we get the 7. So it's — I mean we are plainly concentrated on that since that's what our compensation program rewards. And so what I'd like to say regarding this company's culture is high integrity, intensely focused on generating shareholder value, and that we attempt to accomplish that via everything we do, and customer satisfaction is what propels that; we want customers who are absolutely delighted, and that carries over into our new business plan with sanitizer as well. I think we've got the team that does cost, I mean. Mike is a, is a cost-cutting machine to and creating value. So I think taking cost out is one thing, keeping it out is another. And so having financial leadership, they can help us sustain that I think is critical as we move forward but pretty, pretty excited about the whole of the team and we're getting there. We still have a few historical issues to resolve that we noted in the press release, but thanks it happened 18 months ago. I'm hoping Mike and the team can manage those and that will let us focus really on the growth and get with that $7 a share.

John Gibson

executive
#25

Alright, I’d simply like to express gratitude to each of you for being here on this call. Hearing more from Ryan is something I genuinely anticipate, especially his skill at handling logistics and supply chain so that we can build a new business and truly build a highly profitable new business. That has simply been exceptional, and I believe the more you hear from him, the greater your confidence will become. I think your confidence will also grow in Koid and Matt as we move ahead on the JP3 side too. Then there’s the entire transmix opportunity, which is somewhat of a technical term for most people who hold shares. But it involves multiple products and a product line in sequence. So first comes diesel, then gasoline, and after that jet fuel, and the challenge is how to ensure there’s no mixing while measuring it in seconds rather than hours. So I mean, this is a genuine chance to prevent them from losing money because too much mixing is allowed, and therefore it acts as a direct profit generator for our customers. In our ECP business, we are starting to get going again on the rigs, and that is quite exciting as our core customers return to work, and we pursue diversification of our customer base there. There are simply many positive developments taking place, and I appreciate that you own shares and support us, and we truly enjoy working on your behalf. With that, I’ll simply say thank you, and we’ll see you soon.

Operator

operator
#26

Everyone, that brings today's session to a close. We appreciate each of you for taking part. At this point, feel free to drop off your lines, and we hope the remainder of your day treats you well.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Flotek Industries, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Flotek Industries, Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Flotek Industries, Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.